| High-quality milk exosomes as oral drug delivery system J Zhong, B Xia, S Shan, A Zheng, S Zhang, J Chen, XJ Liang Biomaterials 277, 121126, 2021 | 140 | 2021 |
| Functionalized macrophage exosomes with panobinostat and PPM1D‐siRNA for diffuse intrinsic pontine gliomas therapy S Shan, J Chen, Y Sun, Y Wang, B Xia, H Tan, C Pan, G Gu, J Zhong, ... Advanced Science 9 (21), 2200353, 2022 | 69 | 2022 |
| Exosome regulation of immune response mechanism: Pros and cons in immunotherapy JM Essola, M Zhang, H Yang, F Li, B Xia, JF Mavoungou, A Hussain, ... Bioactive Materials 32, 124-146, 2024 | 32 | 2024 |
| DNA Damage Inducer Mitoxantrone Amplifies Synergistic Mild‐Photothermal Chemotherapy for TNBC via Decreasing Heat Shock Protein 70 Expression Z Chen, S Li, F Li, C Qin, X Li, G Qing, J Wang, B Xia, F Zhang, L Meng, ... Advanced Science 10 (16), 2206707, 2023 | 31 | 2023 |
| Practicable Applications of Aggregation‐Induced Emission with Biomedical Perspective Y Wang, B Xia, Q Huang, T Luo, Y Zhang, P Timashev, W Guo, F Li, ... Advanced Healthcare Materials 10 (24), 2100945, 2021 | 19 | 2021 |
| Brain‐Targeted Exosomes‐Based Drug Delivery System to Overcome the Treatment Bottleneck of Brainstem Glioma J Chen, S Shan, B Xia, L Zhang, XJ Liang Advanced Functional Materials 33 (33), 2302378, 2023 | 11 | 2023 |
| Immune cell-derived exosomes as promising tools for cancer therapy J Chen, G Zhang, Y Wan, B Xia, Q Ni, S Shan, Z Hu, XJ Liang Journal of Controlled Release 364, 508-528, 2023 | 8 | 2023 |
| Lipid-based intelligent vehicle capabilitized with physical and physiological activation F Zhang, B Xia, J Sun, Y Wang, J Wang, F Xu, J Chen, M Lu, X Yao, ... Research, 2022 | 6 | 2022 |
| Oral Administration Properties Evaluation of Three Milk‐derived Extracellular Vesicles Based on Ultracentrifugation Extraction Methods B Xia, R Hu, J Chen, S Shan, F Xu, G Zhang, Z Zhou, Y Fan, Z Hu, ... Advanced Healthcare Materials, 2401370, 2024 | 2 | 2024 |
| Targeting vaccines to dendritic cells by mimicking the processing and presentation of antigens in xenotransplant rejection J Wang, Y Zhang, Y Jia, H Xing, F Xu, B Xia, W Lai, Y Yuan, X Li, S Shan, ... Nature Biomedical Engineering, 1-14, 2025 | | 2025 |
| Engineered Exosomes with Ouabain for H3K27M‐Mutated DIPG Therapy S Shan, J Chen, G Qing, L Xie, B Xia, C Pan, C Xu, H Fang, Y Wan, ... Advanced Functional Materials 35 (3), 2413286, 2025 | | 2025 |
| Delivery Systems Developed for Treatment Combinations to Improve Adoptive Cell Therapy F Xu, Q Ni, N Gong, B Xia, J Zhang, W Guo, Z Hu, J Li, XJ Liang Advanced Materials 36 (40), 2407525, 2024 | | 2024 |
Xing-Jie LiangNational Center for Nanoscience and Technology, China在 nanoctr.cn 的电子邮件经过验证